興齊眼藥(300573.SZ)擬變更經營範圍
格隆匯 12 月 22日丨興齊眼藥(300573.SZ)公佈,公司於2020年12月22日召開的第三屆董事會第二十三次會議,審議通過了《關於變更公司經營範圍暨修改<瀋陽興齊眼藥股份有限公司章程>部分條款的議案》。具體修訂內容如下:
根據公司經營發展,同意公司經營範圍由“滴眼劑(含激素類)、眼膏劑、眼用凝膠劑、溶液劑(眼用)、吸入製劑、大容量注射劑、塑料瓶、原料藥、保健食品、化粧品生產;藥品檢驗服務;醫療器械生產、銷售;場地租賃、設備租賃;自營和代理各類商品和技術的進出口,但國家限定公司經營或禁止進出口的商品和技術除外。”變更為“許可項目:藥品生產,第二類醫療器械生產,第三類醫療器械生產,保健食品生產,化粧品生產,消毒劑生產(不含危險化學品),衞生用品和一次性使用醫療用品生產,檢驗檢測服務,第三類醫療器械經營,貨物進出口,藥品進出口,技術進出口。一般項目:塑料製品製造,第二類醫療器械銷售,非居住房地產租賃,機械設備租賃,知識產權服務。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.